Augmedix, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Augmedix, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
  • Augmedix, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.45M, a 67.9% decline year-over-year.
  • Augmedix, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$23.8M, a 11.6% decline year-over-year.
  • Augmedix, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.2M, a 21.6% increase from 2022.
  • Augmedix, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$24.4M, a 40% decline from 2021.
  • Augmedix, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.5M, a 11.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$23.8M -$8.45M -$3.42M -67.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$20.4M -$6.5M -$1.26M -24.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-12
Q4 2023 -$19.2M -$4.49M +$1.11M +19.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$20.3M -$4.41M +$1.08M +19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$21.4M -$5.03M +$2.3M +31.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$23.7M -$5.24M +$786K +13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-12
Q4 2022 -$24.4M -$5.6M -$505K -9.91% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$23.9M -$5.49M -$2.75M -101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$21.2M -$7.34M -$2.62M -55.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$18.6M -$6.03M -$1.11M -22.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$17.5M -$5.09M -$1.3M -34.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$16.2M -$2.74M +$1.38M +33.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 -$17.5M -$4.72M -$1.76M -59.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-18
Q1 2021 -$15.8M -$4.92M -$180K -3.79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-18
Q4 2020 -$15.6M -$3.79M +$14.7M +79.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$30.3M -$4.12M -$4.11M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$26.2M -$2.96M -$2.95M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$23.2M -$4.74M -$4.73M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-30
Q4 2019 -$18.5M -$18.5M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-06-30
Q3 2019 -$8.72K* Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-01
Q2 2019 -$8.87K* Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$7.97K* Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.